Benefits and Safety of Long-Term Use of IMR-687 As Monotherapy or in Combination with a Stable Dose of Hydroxyurea (HU) in 2 Adult Sickle Cell Patients
- Resource Type
- Journal
- Source
BLOOD ; NOV 5 2020, 136 4p. Supplement: 1- Subject
- Language
- English
- ISSN
- 15280020